Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic/plasmablastic tumors.

@article{Gudez2005TissueIO,
  title={Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic/plasmablastic tumors.},
  author={Liliana Gu{\'e}dez and Antonio Mart{\'i}nez and Shumei Zhao and Angelica Vivero and Stefania Pittaluga and Maryalice Stetler-Stevenson and Mark Raffeld and William G. Stetler-Stevenson},
  journal={Blood},
  year={2005},
  volume={105 4},
  pages={
          1660-8
        }
}
Tissue inhibitor of metalloproteinase 1 (TIMP-1) is a stromal factor with multiple functions. Overexpression of TIMP-1 correlates with aggressive clinical behavior of a spectrum of tumors. Here, for the first time, we address the role of TIMP-1 in the pathogenesis of B-cell lymphomas. An Epstein-Barr virus (EBV)-negative Burkitt lymphoma cell line with ectopic TIMP-1 expression (TIMP-1JD38) was used to identify genes induced/repressed by TIMP-1. Differentially expressed genes were analyzed by… 
Clinicopathologic implications of tissue inhibitor of metalloproteinase-1-positive diffuse large B-cell lymphoma
TLDR
TIMP-1 expression in diffuse large B-cell lymphoma was not correlated with other prognostic factors including: clinical stage, international prognostic index score, and nongerminal center B- cell phenotype, as well as Epstein–Barr virus infection.
The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling
TLDR
It is demonstrated that TIMP-1 modulates leukemic blasts survival, migration and function via CD63/PI3K/Akt/p21 signaling, and is proposed as a potential novel therapeutic target in leukedmic BM microenvironment.
Tissue inhibitor of metalloproteinase-1 (TIMP-1) regulates mesenchymal stem cells through let-7f microRNA and Wnt/β-catenin signaling
TLDR
It is demonstrated that TIMP-1 is a direct regulator of hMSC functions and a regulatory network in which let-7f modulates Wnt/β-catenin activity is revealed.
Tissue inhibitor of metalloproteinase-1 promotes hematopoietic differentiation via caspase-3 upstream the MEKK1/MEK6/p38α pathway
TLDR
It is demonstrated that TIMP-1 differentiating effect can be extended to the IL-3-dependent myeloid murine 32D cell line and human erythroid progenitors derived from cord blood CD34+ cells.
Immunohistochemical expression of MMP1 and TIMP1 as markers of migration in Hodgkin’s and non-Hodgkin’s lymphoma of the head and neck region (A comparative study)
TLDR
This study showed for the first time the effect of MMP-1 in HL, which is considered to be as an invasive and migratory cell marker and a significant difference was found among the subtypes of NHL in relation to TIMP1.
Role of tissue inhibitor of metalloproteinases-1 in the development of autoimmune lymphoproliferation
TLDR
High osteopontin levels may support high tissue inhibitor of metalloproteinases-1 levels in autoimmune lymphoproliferative syndrome and Dianzani’s autoimmune lymphopoliferative disease, and hence worsen the apoptotic defect in these diseases.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 55 REFERENCES
Tissue inhibitor of metalloproteinase (TIMP)-1 induces differentiation and an antiapoptotic phenotype in germinal center B cells.
TLDR
A role for TIMP-1 in BLs is suggested, and its value as a prognostic factor is supported, as well as upregulation of activation and survival markers.
Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells.
TLDR
TIMP-1, aside from its role in proteinase equilibrium, is an autocrine and paracrine survival factor for H/R-S cells and an immunosuppressive protein expressed in Hodgkin lymphomas.
Tissue inhibitor of metalloproteinases 1 regulation of interleukin-10 in B-cell differentiation and lymphomagenesis.
TLDR
TIMP-1 regulates IL-10 expression in B-cell NHL and, through the inhibition of apoptosis, appears responsible for the negative prognosis associated with IL- 10 expression in these tumors.
In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1.
TLDR
It is demonstrated that TIMP-1 suppresses apoptosis in B cells and suggests a novel activity for TIMp-1 in tissue homeostasis.
Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells.
TLDR
It is demonstrated that TIMP-1 inhibits cell death induced by hydrogen peroxide, Adriamycin, or X-ray irradiation, suggesting that the antiapoptotic activity of TIMp-1 does not depend on its ability to stabilize cell-matrix interactions.
Enhanced mRNA expression of tissue inhibitor of metalloproteinase‐1 (TIMP‐1) in breast carcinomas is correlated with adverse prognosis
TLDR
The data support the multifunctional role of TIMP‐1, particularly its growth‐promoting activity, on the basis of its significant correlation with lymph node metastasis and adverse prognosis.
The role of metalloproteinases and their inhibitors in hematological disorders.
TLDR
The goal of this review is to gather recent studies concerning the properties of MMPs and TIMPs in hematological cells, their regulation of gene expression, their cellular distribution, and their potential role in the pathogenesis of hematology disorders such as inflammation and neoplasia.
Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases.
TLDR
The correlation between the increased TIMP-1 mRNA level and advanced CRC stage noted in this study reflects a possible growth-promoting function for TIMP,1 in human CRC.
Differential involvement of the transcription factor Blimp-1 in T cell-independent and -dependent B cell differentiation to plasma cells.
TLDR
The results suggest that Blimp-1 transcription factor specifically promotes T cell-independent B cell differentiation to plasma cells, probably at preplasma cell stages, in contrast, Tcell-dependent plasma cell formation likely evolves through Blimp-1-independent pathways.
Plasma cell differentiation requires the transcription factor XBP-1
TLDR
XBP-1 transcripts were rapidly upregulated in vitro by stimuli that induce plasma-cell differentiation, and were found at high levels in plasma cells from rheumatoid synovium, and when introduced into B-lineage cells, XBP- 1 initiated plasma- cell differentiation.
...
1
2
3
4
5
...